Douglas A. Abel

Douglas A. Abel

Vorstandsvorsitzender bei
Advanced Aesthetic Technologies, Inc.
64 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Douglas A. Abel currently works at Advanced Aesthetic Technologies, Inc., as President & Chief Executive Officer from 2019.
Mr. Abel also formerly worked at TG Therapeutics, Inc., as President, Chief Executive Officer & Director in 2011, Tarpan Therapeutics, Inc., as President & Chief Executive Officer from 2004 to 2005, Physicians Care Alliance LLC, as Chief Executive Officer from 2013 to 2015, Silhouette Lift, Inc., as President, Chief Executive Officer & Director, Allergan Pharmaceuticals Ltd., Inc., as Director-Botox Marketing from 1987 to 2000, Artes Medical, Inc., as Director, Suneva Medical, Inc., as Director & Executive Vice President, Biogen, Inc., as Vice President-Dermatology Business Unit from 2000 to 2004, and Onset Dermatologics LLC, as Senior Vice President & General Manager.
Mr. Abel received his undergraduate degree from Lafayette College and Masters Business Admin degree from Temple University (Pennsylvania).

Aktive Positionen von Douglas A. Abel

UnternehmenPositionBeginn
Vorstandsvorsitzender 18.02.2019

Ehemalige bekannte Positionen von Douglas A. Abel

UnternehmenPositionEnde
Vorstandsvorsitzender 31.12.2018
Vorstandsvorsitzender 05.01.2015
TG THERAPEUTICS, INC. Präsident 19.06.2009
Präsident 01.04.2005
BIOGEN INC. Corporate Officer/Principal 01.11.2004
Sehen Sie sich die Erfahrung von Douglas A. Abel im Detail an

Ausbildung von Douglas A. Abel

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

78

Beziehungen ersten Grades

12

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen12

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Consumer Non-Durables

Electronic Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Douglas A. Abel